Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Xpert MTB/RIF test regulatory update

FDA approved Cepheid's Xpert MTB/RIF assay to detect Mycobacterium tuberculosis (MTB) infection and resistance to

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE